Issue 54, 2016, Issue in Progress

Docetaxel-loaded SiO2@Au@GO core–shell nanoparticles for chemo-photothermal therapy of cancer cells

Abstract

The multifunctional antitumor SiO2@Au@GO core–shell nanoparticles (NPs) have been fabricated for serving as drug nanocarrier and photothermal inducer. The core–shell NPs exhibited high loading capacity of docetaxel (Dtxl) and pH-dependent drug release property as well as low cytotoxicity (concentration < 0.2 mg mL−1). Compared with chemotherapy alone, human prostate cancer cell incubated with Dtxl-loaded SiO2@Au@GO NPs in vitro were found to have undergone morbidity on exposure to near-infrared (NIR) light (780 nm, 5 W cm−2). It is expected that the multifunctional nanoparticles with unique core–shell structure will lead to new opportunities in nanomedicine.

Graphical abstract: Docetaxel-loaded SiO2@Au@GO core–shell nanoparticles for chemo-photothermal therapy of cancer cells

Supplementary files

Article information

Article type
Paper
Submitted
12 Feb 2016
Accepted
28 Apr 2016
First published
29 Apr 2016

RSC Adv., 2016,6, 48379-48386

Docetaxel-loaded SiO2@Au@GO core–shell nanoparticles for chemo-photothermal therapy of cancer cells

X. Li, Z. Yang, N. Hu, L. Zhang, Y. Zhang and L. Yin, RSC Adv., 2016, 6, 48379 DOI: 10.1039/C6RA03886G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements